Apolipoprotein E reduces food intake via PI3K/Akt signaling pathway in the hypothalamus

Ling Shen, David Q.H. Wang, Patrick Tso, Ronald J. Jandacek, Stephen C. Woods, Min Liu

Research output: Contribution to journalArticle

15 Citations (Scopus)

Abstract

Apolipoprotein E (apoE) is a satiation factor. While central apoE administration reduces food intake, the specific intracellular signaling mechanisms activated by apoE remain largely unknown. Using primary cultured hypothalamic neurons, we demonstrated that apoE treatment (50 nM) elicited rapid activation of the phosphatidylinositol-3-kinase (PI3K)/Akt signaling cascade. Specifically, apoE induced the phosphorylation of Akt, peaking at 30 min, and the increased phosphorylation of Akt was significantly attenuated after pretreatment with LY294002 (50. μM), an inhibitor of the PI3K signaling pathway. To determine whether the activation of PI3K by apoE is required for the ability of apoE to reduce food intake, LY294002 (1 nmol) was infused into the 3rd-cerebral ventricle before injection of an anorectic dose of apoE. Consistent with our previous report, apoE (4. μg) exerted significant reduction of food intake in the 4-h fasted rats, compared with saline. Pretreatment with LY294002 significantly attenuated the potency of exogenous apoE to induce satiation, while the same dose of PI3K inhibitor by itself caused only a slight non-significant decrease of food intake. These results indicate that the activation of the PI3K/Akt pathway is necessary for the acute effects of apoE on food intake.

Original languageEnglish (US)
Pages (from-to)124-128
Number of pages5
JournalPhysiology and Behavior
Volume105
Issue number1
DOIs
StatePublished - Nov 30 2011
Externally publishedYes

Fingerprint

Phosphatidylinositol 3-Kinase
Apolipoproteins E
Hypothalamus
Eating
2-(4-morpholinyl)-8-phenyl-4H-1-benzopyran-4-one
Satiation
Phosphorylation
Apolipoprotein E4
Appetite Depressants
Cerebral Ventricles
Third Ventricle
Aptitude

Keywords

  • Apolipoprotein
  • Body weight
  • Food intake
  • Signaling pathway

ASJC Scopus subject areas

  • Experimental and Cognitive Psychology
  • Behavioral Neuroscience

Cite this

Apolipoprotein E reduces food intake via PI3K/Akt signaling pathway in the hypothalamus. / Shen, Ling; Wang, David Q.H.; Tso, Patrick; Jandacek, Ronald J.; Woods, Stephen C.; Liu, Min.

In: Physiology and Behavior, Vol. 105, No. 1, 30.11.2011, p. 124-128.

Research output: Contribution to journalArticle

Shen, Ling ; Wang, David Q.H. ; Tso, Patrick ; Jandacek, Ronald J. ; Woods, Stephen C. ; Liu, Min. / Apolipoprotein E reduces food intake via PI3K/Akt signaling pathway in the hypothalamus. In: Physiology and Behavior. 2011 ; Vol. 105, No. 1. pp. 124-128.
@article{8d504c39e8a348d19bd44619c72988e9,
title = "Apolipoprotein E reduces food intake via PI3K/Akt signaling pathway in the hypothalamus",
abstract = "Apolipoprotein E (apoE) is a satiation factor. While central apoE administration reduces food intake, the specific intracellular signaling mechanisms activated by apoE remain largely unknown. Using primary cultured hypothalamic neurons, we demonstrated that apoE treatment (50 nM) elicited rapid activation of the phosphatidylinositol-3-kinase (PI3K)/Akt signaling cascade. Specifically, apoE induced the phosphorylation of Akt, peaking at 30 min, and the increased phosphorylation of Akt was significantly attenuated after pretreatment with LY294002 (50. μM), an inhibitor of the PI3K signaling pathway. To determine whether the activation of PI3K by apoE is required for the ability of apoE to reduce food intake, LY294002 (1 nmol) was infused into the 3rd-cerebral ventricle before injection of an anorectic dose of apoE. Consistent with our previous report, apoE (4. μg) exerted significant reduction of food intake in the 4-h fasted rats, compared with saline. Pretreatment with LY294002 significantly attenuated the potency of exogenous apoE to induce satiation, while the same dose of PI3K inhibitor by itself caused only a slight non-significant decrease of food intake. These results indicate that the activation of the PI3K/Akt pathway is necessary for the acute effects of apoE on food intake.",
keywords = "Apolipoprotein, Body weight, Food intake, Signaling pathway",
author = "Ling Shen and Wang, {David Q.H.} and Patrick Tso and Jandacek, {Ronald J.} and Woods, {Stephen C.} and Min Liu",
year = "2011",
month = "11",
day = "30",
doi = "10.1016/j.physbeh.2011.04.018",
language = "English (US)",
volume = "105",
pages = "124--128",
journal = "Physiology and Behavior",
issn = "0031-9384",
publisher = "Elsevier Inc.",
number = "1",

}

TY - JOUR

T1 - Apolipoprotein E reduces food intake via PI3K/Akt signaling pathway in the hypothalamus

AU - Shen, Ling

AU - Wang, David Q.H.

AU - Tso, Patrick

AU - Jandacek, Ronald J.

AU - Woods, Stephen C.

AU - Liu, Min

PY - 2011/11/30

Y1 - 2011/11/30

N2 - Apolipoprotein E (apoE) is a satiation factor. While central apoE administration reduces food intake, the specific intracellular signaling mechanisms activated by apoE remain largely unknown. Using primary cultured hypothalamic neurons, we demonstrated that apoE treatment (50 nM) elicited rapid activation of the phosphatidylinositol-3-kinase (PI3K)/Akt signaling cascade. Specifically, apoE induced the phosphorylation of Akt, peaking at 30 min, and the increased phosphorylation of Akt was significantly attenuated after pretreatment with LY294002 (50. μM), an inhibitor of the PI3K signaling pathway. To determine whether the activation of PI3K by apoE is required for the ability of apoE to reduce food intake, LY294002 (1 nmol) was infused into the 3rd-cerebral ventricle before injection of an anorectic dose of apoE. Consistent with our previous report, apoE (4. μg) exerted significant reduction of food intake in the 4-h fasted rats, compared with saline. Pretreatment with LY294002 significantly attenuated the potency of exogenous apoE to induce satiation, while the same dose of PI3K inhibitor by itself caused only a slight non-significant decrease of food intake. These results indicate that the activation of the PI3K/Akt pathway is necessary for the acute effects of apoE on food intake.

AB - Apolipoprotein E (apoE) is a satiation factor. While central apoE administration reduces food intake, the specific intracellular signaling mechanisms activated by apoE remain largely unknown. Using primary cultured hypothalamic neurons, we demonstrated that apoE treatment (50 nM) elicited rapid activation of the phosphatidylinositol-3-kinase (PI3K)/Akt signaling cascade. Specifically, apoE induced the phosphorylation of Akt, peaking at 30 min, and the increased phosphorylation of Akt was significantly attenuated after pretreatment with LY294002 (50. μM), an inhibitor of the PI3K signaling pathway. To determine whether the activation of PI3K by apoE is required for the ability of apoE to reduce food intake, LY294002 (1 nmol) was infused into the 3rd-cerebral ventricle before injection of an anorectic dose of apoE. Consistent with our previous report, apoE (4. μg) exerted significant reduction of food intake in the 4-h fasted rats, compared with saline. Pretreatment with LY294002 significantly attenuated the potency of exogenous apoE to induce satiation, while the same dose of PI3K inhibitor by itself caused only a slight non-significant decrease of food intake. These results indicate that the activation of the PI3K/Akt pathway is necessary for the acute effects of apoE on food intake.

KW - Apolipoprotein

KW - Body weight

KW - Food intake

KW - Signaling pathway

UR - http://www.scopus.com/inward/record.url?scp=80053447077&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=80053447077&partnerID=8YFLogxK

U2 - 10.1016/j.physbeh.2011.04.018

DO - 10.1016/j.physbeh.2011.04.018

M3 - Article

C2 - 21536059

AN - SCOPUS:80053447077

VL - 105

SP - 124

EP - 128

JO - Physiology and Behavior

JF - Physiology and Behavior

SN - 0031-9384

IS - 1

ER -